Holen Sie sich die Stockscreener-App
4.874
1.66%
0.094
Cytek Biosciences Inc Aktie (CTKB) Neueste Nachrichten
New Cytek Biosciences kit aims to boost high-resolution T cell analysis - Traders Union
Cytek Biosciences (NASDAQ: CTKB) details 2026 votes on board, pay and auditor - Stock Titan
CTKB Technical Analysis | Trend, Signals & Chart Patterns | CYTEK BIOSCIENCES INC (NASDAQ:CTKB) - ChartMill
Cytek Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026 - 富途牛牛
Attachment - GlobeNewswire
Cytek Biosciences, Inc. (CTKB) Reports Q3 Loss, Tops Revenue Estimates - MSN
Cytek Biosciences outlines $205M–$212M 2026 revenue target amid record Q4 and growth in recurring revenue - MSN
Cytek Biosciences sets May 7 webcast for Q1 2026 results - Stock Titan
Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Cytek Biosciences unveils AI-driven single-cell imaging webinar on stem cell heterogeneity - Traders Union
Is Cytek (CTKB) stock underpriced in the market (-1.08%) 2026-04-20Elite Trading Signals - Cổng thông tin điện tử Tỉnh Sơn La
Attendees at ImmunologyAAI 109th meeting explore Cytek Biosciences new technology offerings - Traders Union
Cytek Biosciences, Inc. (CTKB) Stock Analysis: Unveiling a 27.93% Potential Upside for Investors - DirectorsTalk Interviews
249,812 Shares in Cytek Biosciences, Inc. $CTKB Purchased by Tudor Investment Corp ET AL - MarketBeat
Cytek Biosciences (CTKB) Inspiring Confidence With Aurora CS System Updates - Yahoo Finance
Cytek Biosciences unveils 21-color T-cell kit to boost immunoprofiling workflows - Traders Union
Aug Action: Can Cytek Biosciences Inc sustain its profitabilityMarket Growth Summary & Weekly Watchlist of Top Performers - baoquankhu1.vn
Millennium Group reports 6.64M shares in Cytek Biosciences (CTKB) - Stock Titan
Cytek Biosciences streamlines drop charge optimization for small sample workflows - Traders Union
Stock Market Recap: Is Cytek Biosciences Inc stock showing strong momentumTrade Performance Summary & Fast Entry High Yield Stock Tips - baoquankhu1.vn
How does currency impact Cytek (CTKB) Stock | Price at $4.59, Down 0.22%Expert Momentum Signals - Newser
Is Cytek (CTKB) Stock Near Support | Price at $4.58, Up 1.10%Elite Trading Signals - Newser
Cytek Biosciences, Inc. (8EQ.F) stock price, news, quote and history - Yahoo Finance UK
Tudor Investment Corp ET AL Invests $867,000 in Cytek Biosciences, Inc. $CTKB - MarketBeat
Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives $5.38 Consensus PT from Analysts - Defense World
Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Vanguard realignment leaves Cytek (NASDAQ: CTKB) ownership at 0 after amendment - Stock Titan
Nautilus Biotechnology And 2 Other Compelling Penny Stocks For Your Watchlist - sahmcapital.com
EPS Watch: What is the Moat Score of Cytek Biosciences Inc2026 Rallies & Smart Allocation Stock Reports - baoquankhu1.vn
Tranche Update on Cytek Biosciences, Inc.'s Equity Buyback Plan announced on December 30, 2024. - marketscreener.com
CTKB Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Cytek Biosciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Topline Capital Management LLC Has $24.10 Million Position in Cytek Biosciences, Inc. $CTKB - MarketBeat
US Stocks Recap: How does Cytek Biosciences Inc compare to its peersMarket Growth Report & Real-Time Market Sentiment Reports - baoquankhu1.vn
Cytek Biosciences (CTKB) director converts 6,107 RSUs into common stock - Stock Titan
Cytek Biosciences (CTKB) CLO receives new options, 226,453 RSUs and stock from vesting - Stock Titan
Cytek Biosciences (NASDAQ: CTKB) SVP granted options, RSUs and sees RSU vesting - Stock Titan
Cytek Biosciences (CTKB) CEO awarded options, RSUs and surrenders shares for taxes - Stock Titan
Cytek Biosciences (CTKB) CFO receives new equity awards and RSU vesting - Stock Titan
Cytek Biosciences (CTKB) CTO granted stock options and 227,535 RSUs - Stock Titan
Cytek Biosciences (NASDAQ: CTKB) director gains 2,908 shares via RSU vesting - Stock Titan
Latest CTKB NewsAmberstone Biosciences Secures $12 Million ... - Stock Titan
Cytek Biosciences, Inc. (CTKB) Stock Analysis: Unveiling a 44% Potential Upside in the Medical Devices Space - DirectorsTalk Interviews
Sell Signal: What is the Moat Score of Cytek Biosciences IncTrade Performance Summary & AI Driven Stock Price Forecasts - baoquankhu1.vn
Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact - Taiwan News
Cytek Biosciences expands global reach with one year of Singapore operations - Traders Union
Cytek Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact - Bitget
Cytek Biosciences Highlights Aurora Evo, Recurring Revenue Growth and 2026 Outlook at TD Cowen Conference - Yahoo Finance
How The Cytek Biosciences (CTKB) Story Is Shifting With New Targets And 2026 Guidance - Yahoo Finance
Cytek Biosciences Balances Growth With Margin Strain - The Globe and Mail
0.76%
0.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):